Progentec Diagnostics
Latest round
- Series A
Last raised
- Jan 2020
Total raised
- $5M
Investors
- 9
About Progentec Diagnostics
Progentec Diagnostics, Inc.Progentec Diagnostics, Inc. specializes in diagnostic solutions for autoimmune diseases. Founded in 2015, the company is headquartered in Oklahoma City, US.000 mn.Progentec Diagnostics, Inc. specializes in innovative diagnostic solutions aimed at managing autoimmune diseases, particularly lupus and multiple sclerosis (MS). The company's flagship product, the aiSLE™ DX Flare Risk Index, utilizes proprietary LiquidFlareRisk™ Technology to assess the risk of lupus patients experiencing disease-related flares within a 12-week timeframe. Released in April 2020, this molecular diagnostic test provides critical insights that traditional disease activity scales do not offer. Additionally, Progentec is developing biological and digital biomarkers that enhance the monitoring of MS disease progression, employing blood tests and cognitive assessments.Progentec Diagnostics operates within a transactional framework encompassing direct-to-consumer and business-to-business engagements. The company generates revenue through the sale of diagnostic tests, including the aiSLE™ DX Flare Risk Index, to medical facilities and laboratories, such as Mayo Clinic Laboratories.Progentec Diagnostics is focused on expanding its product line and market presence. The company plans to launch new products designed to enhance autoimmune disease management by mid-2023.000 mn will be utilized to support the development and market introduction of these upcoming products, as well as to facilitate expansion into new geographic regions, specifically targeting European and Asian markets by 2024. This strategic approach aims to leverage their existing platforms and collaborations to improve healthcare outcomes for patients with autoimmune conditions.
Who invested in Progentec Diagnostics
9 investors across 1 round
See all investors in Progentec Diagnostics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 8, 2020
Amount
$5M
Investors
Questions about Progentec Diagnostics
Who invested in Progentec Diagnostics?
Progentec Diagnostics has 9 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Progentec Diagnostics raised?
Progentec Diagnostics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Progentec Diagnostics last raise money?
Progentec Diagnostics's most recent round on record is a Series A, in Jan 2020.
What does Progentec Diagnostics do?
Progentec Diagnostics is a healthcare company.
Where is Progentec Diagnostics headquartered?
Progentec Diagnostics is headquartered in Oklahoma City, US.
Which VCs invest in companies like Progentec Diagnostics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Kleiner Perkins and Lightspeed Venture Partners back healthcare companies at Progentec Diagnostics's stage. Their profiles are linked below.
VCs backing healthcare startups at Series A
Raising like Progentec Diagnostics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.